---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-001085"
form_type: "8-K"
ticker: "CCCC"
cik: "0001662579"
company_name: "C4 Therapeutics, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:34:44.517718+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# C4 Therapeutics posts investor presentation; announces restructuring to preserve cash runway into 2027

## Summary
- Company posted investor presentation on January 11, 2024, detailing a restructuring plan.
- Restructuring expected to preserve cash runway into 2027.
- Estimated charges and costs for restructuring to be incurred in connection with cost-saving initiatives.
- Forward-looking statements include expectations on timing, costs, and efficiencies from the restructuring.

## SEC filing metadata
- accession: 0001628280-24-001085
- form_type: 8-K
- ticker: CCCC
- cik: 0001662579
- company_name: C4 Therapeutics, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/0001628280-24-001085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662579/000162828024001085/cccc-20240111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-001085
- JSON: https://secwatch.observer/filing/0001628280-24-001085.json
- Plain text: https://secwatch.observer/filing/0001628280-24-001085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.